Article
Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in mice
2023-06-12
Abstract excerpt
<title>Abstract</title> <p>Background Recent advances in gene editing technology have opened up new avenues for <italic>in vivo</italic> gene therapy, which holds great promise as a potential treatment method for dilated cardiomyopathy (DCM). The CRISPR-Cas13 system has been shown to be an effective tool for knocking down RNA expression in mammalian cells. Results In this study, we delivered PspCas13b with <ita...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2075494a-5c85-596c-a18e-a66e94ee1392
- DOI
- 10.21203/rs.3.rs-2944961/v1
